|
BTN2A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.021300E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.438510E-04 |
| Normal-vs-Stage2 |
4.361200E-01 |
| Normal-vs-Stage3 |
1.159780E-01 |
| Normal-vs-Stage4 |
1.762470E-02 |
| Stage1-vs-Stage2 |
1.569620E-01 |
| Stage1-vs-Stage3 |
3.015400E-01 |
| Stage1-vs-Stage4 |
8.787000E-01 |
| Stage2-vs-Stage3 |
6.757600E-01 |
| Stage2-vs-Stage4 |
3.403600E-01 |
| Stage3-vs-Stage4 |
4.565200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.997400E-04 |
| Normal-vs-AfricanAmerican |
5.126200E-02 |
| Normal-vs-Asian |
2.769800E-01 |
| Caucasian-vs-AfricanAmerican |
4.889400E-01 |
| Caucasian-vs-Asian |
7.024400E-01 |
| AfricanAmerican-vs-Asian |
9.105200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.14170000000836E-05 |
| Normal-vs-Female |
3.099400E-01 |
| Male-vs-Female |
1.161800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.283700E-02 |
| Normal-vs-Extreme_Weight |
6.06159999999578E-05 |
| Normal-vs-Obese |
5.433700E-02 |
| Normal-vs-Extreme_Obese |
2.142000E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.865770E-01 |
| Normal_Weight-vs-Obese |
6.664600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.440200E-01 |
| Extreme_Weight-vs-Obese |
2.285700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.132000E-01 |
| Obese-vs-Extreme_Obese |
1.790980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.258200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.875850E-02 |
| Normal-vs-Age(61-80Yrs) |
3.394200E-04 |
| Normal-vs-Age(81-100Yrs) |
1.602340E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.413000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.324400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.843400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.284970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.474400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.836790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.015320E-03 |
| Normal-VS-Type2 PRCC |
6.218000E-04 |
| Normal-VS-KIRP CIMP |
6.214800E-01 |
| Normal-VS-Unclassified PRCC |
1.779020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.506200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.610000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.887400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.456200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.996040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.608800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.754900E-04 |
| Normal-vs-N1 |
6.613000E-01 |
| Normal-vs-N2 |
3.622200E-03 |
| N0-vs-N1 |
3.163600E-02 |
| N0-vs-N2 |
3.165800E-01 |
| N1-vs-N2 |
1.253580E-01 |
|
|
